David Kessenich is Chairman, Managing Partner, and Co-Founder of Excellere Partners, and has more than 30 years of principal investing and investment banking experience, including leading investment teams, originating investment opportunities, providing strategic and operational oversight, and board governance. He chairs the firm’s Investment and Portfolio Governance Committees and is a member of the firm’s Management Committee. Mr. Kessenich has helped build Excellere Partners with a vision and culture of supporting entrepreneurs as they work to successfully grow their companies into best-in-class, industry leading businesses. He has extensive industry experience, including healthcare services, medical technology, and life sciences; energy services spanning the upstream, midstream and downstream continuum; industrial technology and specialty chemicals; and transportation logistics. Prior to forming Excellere Partners in 2006, Mr. Kessenich was a senior investment professional and served on the investment committees at three highly successful private equity firms. Prior to that, Mr. Kessenich was an investment banker with Continental Bank / Bank of America, where he advised middle-market entrepreneurs and companies raising debt and equity capital.
Mr. Kessenich received an MBA in Finance and International Business from The University of Chicago's Graduate School of Business and a BSBA in Accounting and Finance from Creighton University. Mr. Kessenich currently serves on the board of directors of Biocare Medical (Life Sciences), G2 Integrated Solutions (Energy Services), LucidHealth (Radiology Physician Practice), Medlogix (Medical Claims Management), SePRO (Specialty Chemicals), and TL Life Sciences Solutions (Pharma Services). Mr. Kessenich previously served on the board of directors of Advanced Pain Management, AxelaCare Health Solutions, Integrated Petroleum Technologies, MedExpress Urgent Care, MTS Medication Technologies, Personable Insurance, PhyMed Anesthesia and U.S. Water Services prior to their sales.